Angiotensin Converting Enzyme (ACE) Inhibitors Market
Angiotensin Converting Enzyme (ACE) Inhibitors Strategic Research Report 2024-2030: Increasing Focus on Lifestyle Management and Preventive Care Sustains Demand f
30 oct. 2024 11h48 HE | Research and Markets
Dublin, Oct. 30, 2024 (GLOBE NEWSWIRE) -- The "Angiotensin Converting Enzyme (ACE) Inhibitors - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The...
22157.jpg
Atrial Fibrillation Drug Pipeline Research Report 2024: Therapeutic Assessment, Emerging Drugs, Pipeline Development Activities, Competitive Landscape
14 oct. 2024 10h37 HE | Research and Markets
Dublin, Oct. 14, 2024 (GLOBE NEWSWIRE) -- The "Atrial Fibrillation - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.This "Atrial Fibrillation - Pipeline...
Global Angina Pectoris Drugs Market
Global Angina Pectoris Drugs Market Set for Growth Amid Advancements in Healthcare Infrastructure
11 mars 2024 09h01 HE | Research and Markets
Dublin, March 11, 2024 (GLOBE NEWSWIRE) -- The "Global Angina Pectoris Drugs Market by Type, by Drugs, by Route of Administration, by End-Users, and By Region" report has been added to ...
22157.jpg
Hypertrophic Cardiomyopathy Therapeutics Market Predicted to Reach $1.48 Billion by 2028, Driven by Advances in Personalized Medicine and Genetic Testing - Long-term Forecasts to 2033
31 janv. 2024 07h45 HE | Research and Markets
Dublin, Jan. 31, 2024 (GLOBE NEWSWIRE) -- The "Hypertrophic Cardiomyopathy (HCM) Therapeutics Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering. The...
22157.jpg
Antihypertensive Drug Market to Expand with Promising CAGR of 4.7% through 2030: Regional Growth Opportunities for Diuretics, ACE Inhibitors, Calcium Channel Blockers, Vasodilators, Beta-Adrenergic Blockers
30 janv. 2024 07h11 HE | Research and Markets
Dublin, Jan. 30, 2024 (GLOBE NEWSWIRE) -- The "Antihypertensive Drug Market Report: Trends, Forecast and Competitive Analysis to 2030" report has been added to ResearchAndMarkets.com's offering. ...
Global Ischemic Heart Disease (IHD) Drugs Market
Global Ischemic Heart Disease (IHD) Drugs Market Set to Expand, Projected Value of $7.9 Billion by 2028
21 sept. 2023 09h58 HE | Research and Markets
Dublin, Sept. 21, 2023 (GLOBE NEWSWIRE) -- The "Ischemic Heart Disease Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028" report has been added to ...
Global Angina Pectoris Drugs Market
Specialty Clinics Emerge as Key End-Users in the Global Angina Pectoris Drugs Market 2023-2030
20 sept. 2023 06h23 HE | Research and Markets
Dublin, Sept. 20, 2023 (GLOBE NEWSWIRE) -- The "Global Angina Pectoris Drugs Market by Type, Drugs, Route of Administration, End-Users - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and...
22157.jpg
Global Antihypertensive Drugs Market Outlook 2023-2030 by Therapy, Type of Drug, and Region
26 juil. 2023 05h08 HE | Research and Markets
Dublin, July 26, 2023 (GLOBE NEWSWIRE) -- The Global Antihypertensive Drugs Market Outlook 2023-2030 report has been added to ResearchAndMarkets.com's offering. The Global Antihypertensive Drugs...
researchdrivelogo.jpg
Global Nephrology Drugs Market Projected to Garner a Revenue of $21,454.5 Million and Rise at a CAGR of 6.0% during the Forecast Period 2021-2028 [170-Pages] | Exclusive by Research Dive
06 févr. 2023 09h01 HE | Research Dive
New York, USA, Feb. 06, 2023 (GLOBE NEWSWIRE) -- According to a report published by Research Dive, the global nephrology drugs market is anticipated to generate a revenue of $21,454.5 million and...
22157.jpg
Outlook on the Angina Pectoris Treatment Global Market to 2030 - by Drug Class and Region
31 janv. 2023 09h28 HE | Research and Markets
Dublin, Jan. 31, 2023 (GLOBE NEWSWIRE) -- The "Angina Pectoris Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and...